Skip to main content

Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.

Publication ,  Journal Article
Fradley, MG; Beckie, TM; Brown, SA; Cheng, RK; Dent, SF; Nohria, A; Patton, KK; Singh, JP; Olshansky, B
Published in: Circulation
July 20, 2021

With the advent of novel cancer therapeutics and improved screening, more patients are surviving a cancer diagnosis or living longer with advanced disease. Many of these treatments have associated cardiovascular toxicities that can manifest in both an acute and a delayed fashion. Arrhythmias are an increasingly identified complication with unique management challenges in the cancer population. The purpose of this scientific statement is to summarize the current state of knowledge regarding arrhythmia identification and treatment in patients with cancer. Atrial tachyarrhythmias, particularly atrial fibrillation, are most common, but ventricular arrhythmias, including those related to treatment-induced QT prolongation, and bradyarrhythmias can also occur. Despite increased recognition, dedicated prospective studies evaluating true incidence are lacking. Moreover, few studies have addressed appropriate prevention and treatment strategies. As such, this scientific statement serves to mobilize the cardio-oncology, electrophysiology, and oncology communities to develop clinical and scientific collaborations that will improve the care of patients with cancer who have arrhythmias.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 20, 2021

Volume

144

Issue

3

Start / End Page

e41 / e55

Location

United States

Related Subject Headings

  • Thrombosis
  • Signal Transduction
  • Severity of Illness Index
  • Neoplasms
  • Immunotherapy
  • Humans
  • Electrocardiography
  • Disease Susceptibility
  • Disease Management
  • Diagnosis, Differential
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fradley, M. G., Beckie, T. M., Brown, S. A., Cheng, R. K., Dent, S. F., Nohria, A., … Olshansky, B. (2021). Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation, 144(3), e41–e55. https://doi.org/10.1161/CIR.0000000000000986
Fradley, Michael G., Theresa M. Beckie, Sherry Ann Brown, Richard K. Cheng, Susan F. Dent, Anju Nohria, Kristen K. Patton, Jagmeet P. Singh, and Brian Olshansky. “Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.Circulation 144, no. 3 (July 20, 2021): e41–55. https://doi.org/10.1161/CIR.0000000000000986.
Fradley MG, Beckie TM, Brown SA, Cheng RK, Dent SF, Nohria A, et al. Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation. 2021 Jul 20;144(3):e41–55.
Fradley, Michael G., et al. “Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.Circulation, vol. 144, no. 3, July 2021, pp. e41–55. Pubmed, doi:10.1161/CIR.0000000000000986.
Fradley MG, Beckie TM, Brown SA, Cheng RK, Dent SF, Nohria A, Patton KK, Singh JP, Olshansky B. Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association. Circulation. 2021 Jul 20;144(3):e41–e55.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 20, 2021

Volume

144

Issue

3

Start / End Page

e41 / e55

Location

United States

Related Subject Headings

  • Thrombosis
  • Signal Transduction
  • Severity of Illness Index
  • Neoplasms
  • Immunotherapy
  • Humans
  • Electrocardiography
  • Disease Susceptibility
  • Disease Management
  • Diagnosis, Differential